NCT01592097View on ClinicalTrials.gov

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Multiple Sclerosis
Trial Locations (1)

90033

Keck School of Medicine of the University of Southern Calfornia, Los Angeles

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Southern California

OTHER